NXTCL — NextCell Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK126.39m
- SEK94.06m
- SEK13.70m
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln
Brief: NextCell Pharma Enters Collaboration With OptiCell Solutions
Brief: Nextcell Pharma Appoints Eric Gustafsson As CFO
Brief: Nextcell Pharma Q4 Operating Income SEK 2.5 Mln
Brief: NextCell Pharma Q4 Operating Income SEK 2.522 Million
Brief: Nextcell Pharma Cfo Patrik Fagerholm To Step Down
Brief: NextCell Pharma Q3 Operating Income SEK 2.262 Million
Brief: Nextcell Gets U.S. Patent For MSC Prediction Algorithm
Brief: Nextcell Announces Strategic Collaboration With Fujifilm Irvine Scientific
Brief: NextCell Pharma Q2 Operating Income SEK 3.417 Million
Brief: Nextcell Pharma Q1 Net Sales At SEK 2.8 Mln
Brief: Nextcell Pharma: Long-Term Effects With Repeated Protrans Treatment After 6 Years
Brief: Nextcell Pharma Announces Qvance Partnership With Royale International
Brief: Nextcell Pharma Unit Qvance Enters Into Partnership With Biomérieux Sweden
Brief: NextCell Pharma Q4 Operating Income SEK 1.696 Million
Brief: NextCell Pharma Q3 Operating Income SEK 2.482 Million